SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001370368-23-000059
Filing Date
2023-07-18
Accepted
2023-07-18 07:30:53
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K nvs-20230630.htm   iXBRL 6-K 11573
2 99.1 FINANCIAL REPORT Q2 2023 nvs-20230630-99_1.htm EX-99 277333
3 99.2 INTERIM FINANCIAL REPORT nvs-20230630-99_2.htm   iXBRL EX-99 4299945
9 IMAGE logo.jpg GRAPHIC 26773
10 IMAGE coverifr.jpg GRAPHIC 313215
  Complete submission text file 0001370368-23-000059.txt   18108129

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nvs-20230630_cal.xml EX-101.CAL 124928
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nvs-20230630_def.xml EX-101.DEF 455188
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT nvs-20230630_lab.xml EX-101.LAB 1875093
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvs-20230630_pre.xml EX-101.PRE 474673
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvs-20230630.xsd EX-101.SCH 530001
55 EXTRACTED XBRL INSTANCE DOCUMENT nvs-20230630_htm.xml XML 3972394
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 231093008
SIC: 2834 Pharmaceutical Preparations